Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Authors: Moldovan, D.1 moldovan.dumitru@gmail.com, Reshef, A.2, Fabiani, J.3, Kivity, S.4, Toubi, E.5, Shlesinger, M.6, Triggiani, M.7, Montinaro, V.8, Cillari, E.9, Realdi, G.10, Cancian, M.10, Visscher, S.11, Zanichelli, A.12, Relan, A.11, Cicardi, M.12
Source: Clinical & Experimental Allergy. Jun2012, Vol. 42 Issue 6, p929-935. 7p. 7 Charts, 3 Graphs.
Database: Environment Complete
Description
ISSN:09547894
DOI:10.1111/j.1365-2222.2012.03984.x